Advertisement
Singapore markets closed

  • Straits Times Index

    3,426.47
    -3.98 (-0.12%)
     

  • Nikkei

    37,667.41
    -202.10 (-0.53%)
     

  • Hang Seng

    17,021.31
    +16.34 (+0.10%)
     

  • FTSE 100

    8,285.71
    +99.36 (+1.21%)
     

  • Bitcoin USD

    68,014.59
    +900.78 (+1.34%)
     

  • CMC Crypto 200

    1,372.40
    +41.80 (+3.14%)
     

  • S&P 500

    5,459.10
    +59.88 (+1.11%)
     

  • Dow

    40,589.34
    +654.27 (+1.64%)
     

  • Nasdaq

    17,357.88
    +176.16 (+1.03%)
     

  • Gold

    2,385.70
    +32.20 (+1.37%)
     

  • Crude Oil

    76.44
    -1.84 (-2.35%)
     

  • 10-Yr Bond

    4.2000
    -0.0560 (-1.32%)
     

  • FTSE Bursa Malaysia

    1,612.88
    -2.30 (-0.14%)
     

  • Jakarta Composite Index

    7,288.17
    +47.89 (+0.66%)
     

  • PSE Index

    6,726.01
    +55.74 (+0.84%)
     

IHH Healthcare’s indirect subsidiary to withdraw IPO plans

Felicia Tan
·1-min read

As at 3.33pm, shares in IHH are trading flat at $1.74.

Agilus Diagnostics, the 31.17%-owned indirect subsidiary of IHH Healthcare Q0f and a material subsidiary of Fortis Healthcare, is cancelling its plans to hold an initial public offering (IPO) on the Securities and Exchange Board of India (SEBI)

According to IHH, the private equity investors, as well as the board of directors at Fortis and Agilus, have agreed to withdraw the draft red herring prospectus following meetings held on Feb 13.

Agilus will apply to the SEBI to withdraw its prospectus immediately and may re-file with the exchange for a proposed IPO in future.

As at 3.33pm, shares in IHH are trading flat at $1.74.

See Also: